The pathogenesis of multiple system atrophy: Past, present, and future

Multiple system atrophy is a sporadic, adult‐onset neurodegenerative disease of unknown etiology. The condition may be unique among neurodegenerative diseases by the prominent, if not primary, role played by the oligodendroglial cell in the pathogenetic process. Recent developments in our understanding of multiple system atrophy have included the detection of glial cytoplasmic inclusions and α‐synuclein accumulation in these inclusions. The latter finding links multiple system atrophy as an “α‐synucleinopathy” to Parkinson's disease and dementia with Lewy bodies. This article reviews recent important findings of potential relevance to the pathogenesis of multiple system atrophy. We also speculate on areas in which further advances may be made to progress our understanding of this devastating condition.

[1]  S. Tsuji,et al.  No mutation in the entire coding region of the α-synuclein gene in pathologically confirmed cases of multiple system atrophy , 1999, Neuroscience Letters.

[2]  L. Petrucelli,et al.  α-Synuclein Shares Physical and Functional Homology with 14-3-3 Proteins , 1999, The Journal of Neuroscience.

[3]  M. Tolnay,et al.  REVIEW: tau protein pathology in Alzheimer’s disease and related disorders , 1999, Neuropathology and applied neurobiology.

[4]  P. Worley,et al.  Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions , 1999, Nature Genetics.

[5]  R. Krüger,et al.  Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype , 1999, Annals of neurology.

[6]  M. Citron,et al.  Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation* , 1999, The Journal of Biological Chemistry.

[7]  J B Schulz,et al.  Caspases as treatment targets in stroke and neurodegenerative diseases , 1999, Annals of neurology.

[8]  P. Canoll,et al.  GGF/Neuregulin Induces a Phenotypic Reversion of Oligodendrocytes , 1999, Molecular and Cellular Neuroscience.

[9]  I Litvan,et al.  Consensus statement on the diagnosis of multiple system atrophy , 1998, Journal of the Neurological Sciences.

[10]  E. Jaros,et al.  Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. , 1998, Neuroreport.

[11]  Y Sakaki,et al.  Cloning and mapping of ZNF231, a novel brain-specific gene encoding neuronal double zinc finger protein whose expression is enhanced in a neurodegenerative disorder, multiple system atrophy (MSA). , 1998, Genomics.

[12]  Shigeo Hirai,et al.  NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy , 1998, Acta Neuropathologica.

[13]  Hitoshi Takahashi,et al.  Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy , 1998, Acta Neuropathologica.

[14]  J Q Trojanowski,et al.  Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein , 1998, Annals of neurology.

[15]  A. Schapira,et al.  The role of the α-synuclein gene mutation in patients with sporadic Parkinson’s disease in the United Kingdom , 1998, Journal of neurology, neurosurgery, and psychiatry.

[16]  K. Schmid,et al.  Cell Death Mechanisms in Multiple System Atrophy , 1998, Journal of neuropathology and experimental neurology.

[17]  P. Blumbergs,et al.  Multiple-system atrophy: a new α-synuclein disease? , 1998, The Lancet.

[18]  Nigel J. Cairns,et al.  Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.

[19]  J. Kimura,et al.  Cyclin-dependent Kinase 5 and Mitogen-activated Protein Kinase in Glial Cytoplasmic Inclusions in Multiple System Atrophy , 1998, Journal of neuropathology and experimental neurology.

[20]  J. Wands,et al.  P53- and CD95-associated apoptosis in neurodegenerative diseases. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[21]  C. Tanner,et al.  Absence of mutations in the coding region of the α-synuclein gene in pathologically proven Parkinson's disease , 1998, Neurology.

[22]  Lin Jin,et al.  Aberrant RNA Processing in a Neurodegenerative Disease: the Cause for Absent EAAT2, a Glutamate Transporter, in Amyotrophic Lateral Sclerosis , 1998, Neuron.

[23]  L. Role,et al.  A Cysteine-Rich Isoform of Neuregulin Controls the Level of Expression of Neuronal Nicotinic Receptor Channels during Synaptogenesis , 1998, Neuron.

[24]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[25]  Michael Sasner,et al.  Neuregulin-β induces expression of an NMDA-receptor subunit , 1997, Nature.

[26]  Y. Yarden,et al.  Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiation , 1997, Oncogene.

[27]  A. Welcher,et al.  Effect of neu differentiation factor isoforms on neonatal oligodendrocyte function , 1997, Journal of neuroscience research.

[28]  C. Marsden,et al.  Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration , 1997, Neurology.

[29]  S. Paul,et al.  Involvement of a Caspase‐3‐Like Cysteine Protease in 1‐Methyl‐4‐Phenylpyridinium‐Mediated Apoptosis of Cultured Cerebellar Granule Neurons , 1997, Journal of neurochemistry.

[30]  M. Oda,et al.  Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy , 1997, Neuroscience Letters.

[31]  P. Lantos,et al.  Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease , 1997, Neuroscience Letters.

[32]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[33]  Kazuko Hasegawa,et al.  The distribution and dynamic density of oligodendroglial cytoplasmic inclusions (GCIs) in multiple system atrophy: a correlation between the density of GCIs and the degree of involvement of striatonigral and olivopontocerebellar systems , 1997, Acta Neuropathologica.

[34]  Yosef Yarden,et al.  Neuregulins and Their Receptors: A Versatile Signaling Module in Organogenesis and Oncogenesis , 1997, Neuron.

[35]  J. Mcculloch,et al.  Rapid Alteration of Tau in Oligodendrocytes After Focal Ischemic Injury in the Rat: Involvement of Free Radicals , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  C. Richter-Landsberg,et al.  Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes , 1997, Cell and Tissue Research.

[37]  G. Fischbach,et al.  Axonal Neuregulin Signals Cells of the Oligodendrocyte Lineage through Activation of HER4 and Schwann Cells through HER2 and HER3 , 1997, The Journal of cell biology.

[38]  N. Quinn,et al.  Multiple system atrophy: A review of 203 pathologically proven cases , 1997, Movement disorders : official journal of the Movement Disorder Society.

[39]  Andrew J Lees,et al.  Apolipoprotein E e4 allele frequency in patients with multiple system atrophy , 1997, Neuroscience Letters.

[40]  D. Graham,et al.  Increased tau immunoreactivity in oligodendrocytes following human stroke and head injury , 1996, Neuroscience Letters.

[41]  P. Canoll,et al.  GGF/Neuregulin Is a Neuronal Signal That Promotes the Proliferation and Survival and Inhibits the Differentiation of Oligodendrocyte Progenitors , 1996, Neuron.

[42]  M. Pericak-Vance,et al.  Genetic studies in Alzheimer's disease with an NACP/α‐synuclein polymorphism , 1996 .

[43]  T. Reh,et al.  Effects of GGF/neuregulins on neuronal survival and neurite outgrowth correlate with erbB2/neu expression in developing rat retina. , 1996, Development.

[44]  N. Quinn,et al.  Arg296 to Cys296 polymorphism in exon 6 of cytochrome P-450-2D6 (CYP2D6) is not associated with multiple system atrophy. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[45]  David F. Clayton,et al.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch , 1995, Neuron.

[46]  H. Mizusawa,et al.  Ubiquitinated αB-crystallin in glial cytoplasmic inclusions from the brain of a patient with multiple system atrophy , 1995, Journal of the Neurological Sciences.

[47]  K. Iwahashi,et al.  A novel cytochrome P-450IID6 (CYPIID6) mutant gene associated with multiple system atrophy. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[48]  G. Fischbach,et al.  A role for the acetylcholine receptor-inducing protein ARIA in oligodendrocyte development. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[49]  Michel Goedert,et al.  Identification of two distinct synucleins from human brain , 1994, FEBS letters.

[50]  P. Lantos,et al.  The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. , 1994, Brain : a journal of neurology.

[51]  P. Lantos,et al.  Cellular pathology of multiple system atrophy: a review. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[52]  S. Daniel,et al.  Multiple system atrophy: sporadic or familial? , 1993, The Lancet.

[53]  C. Davie,et al.  MRS to differentiate multiple system atrophy from idiopathic Parkinson's disease , 1993, The Lancet.

[54]  P. Lantos,et al.  Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy , 1992, Journal of the Neurological Sciences.

[55]  Peter L. Lantos,et al.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) , 1989, Journal of the Neurological Sciences.